![Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR](https://www.cdc.gov/mmwr/volumes/71/wr/social-media/mm7148e1-BivalentBooster_IMAGE_22NOV2022_1200x675.jpg?_=65732)
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR
![Por qué la tercera dosis de la vacuna contra la COVID-19 es fundamental contra Ómicron | National Geographic Por qué la tercera dosis de la vacuna contra la COVID-19 es fundamental contra Ómicron | National Geographic](https://static.nationalgeographic.es/files/styles/image_3200/public/ngscience-2112-omicron-protection_primary_ai2html_fallback.jpg?w=1900&h=3188)
Por qué la tercera dosis de la vacuna contra la COVID-19 es fundamental contra Ómicron | National Geographic
![Boosters wane but showed protection against hospitalization during omicron, CDC study says - The Washington Post Boosters wane but showed protection against hospitalization during omicron, CDC study says - The Washington Post](https://arc-anglerfish-washpost-prod-washpost.s3.amazonaws.com/public/HUL3OBDUFYI6ZITNDQQ4C2Y4SM.jpg)
Boosters wane but showed protection against hospitalization during omicron, CDC study says - The Washington Post
![Updated Toolkit: COVID-19 Booster Dose Messaging and Outreach Tools - Public Health Communications Collaborative (PHCC) Updated Toolkit: COVID-19 Booster Dose Messaging and Outreach Tools - Public Health Communications Collaborative (PHCC)](https://publichealthcollaborative.org/wp-content/uploads/2022/10/ENG_Twitter_updated-booster-doses-2-1024x576.png)
Updated Toolkit: COVID-19 Booster Dose Messaging and Outreach Tools - Public Health Communications Collaborative (PHCC)
![Bivalent booster recipients show slightly higher protection against infection and significantly higher protection against death than monovalent booster recipients Bivalent booster recipients show slightly higher protection against infection and significantly higher protection against death than monovalent booster recipients](https://d2jx2rerrg6sh3.cloudfront.net/images/news/ImageForNews_738649_16762847469299512.jpg)